Skip to content

Transcranial direct current stimulation for motor recovery of upper limb function after stroke: a multicenter randomized controlled trial

Transcranial direct current stimulation for motor recovery of upper limb function after stroke: a multicenter randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800015881
Enrollment
Unknown
Registered
2018-04-26
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

tDCS +routine rehabilitation group:tDCS
sham tDCS+routine rehabilitation group:sham tDCS

Sponsors

Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Aged from 40 to 80 years old; (2) cerebral hemorrhage and cerebral infarction occurred for the first time; (3) patients who had suffered from lacunar infarction without sequelae; (4) consistent with the diagnosis of various cerebrovascular diseases passed in the fourth academic conference of cerebrovascular diseases in 1995; (5) confirmed by CT or MRI; (6) upper limb dysfunction from 2 weeks to 3 months; (7) the Brunnstrom stage of the affected limb was graded 1-5; (8) sign the informed consent; (9) all of the above inclusion criteria shall be met.

Exclusion criteria

Exclusion criteria: (1) patients with decompression of bone flap and skull repair after intracerebral hemorrhage; (2) the MMSE evaluation indicated dementia, or combined with sensory aphasia or mental disorder, and was not able to compliance to examination and treatment; (3) patients with severe diseases of heart, liver, kidney and hematopoietic system; (4) previous history of cognitive impairment, neuropsychiatric history, drug abuse and alcoholism; (5) patients with cardiac pacemakers, brain stimulation devices and intracranial metal implantation devices (artery clamps, skull repair); (6) patients with ventriculo-peritoneal shunt; (7) patients with epilepsy who have not been well controlled by drug; (8) unable to compliance to treatment, and difficult to follow up; (9) patients with metal implants on the side upper limbs.

Design outcomes

Primary

MeasureTime frame
MAS;FMA;muscle strength;

Secondary

MeasureTime frame
fMRI;MEP;

Countries

China

Contacts

Public ContactLiu Huihua

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

872251681@qq.com+86 15989193467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026